Foamix to Present Data on its Topical Product Candidates for Acne, Rosacea at 39th Annual Fall Clinical Dermatology Conference
FOAMIX PHARMACEUTICALS LTD (FOMX)
Last foamix pharmaceuticals ltd earnings: 11/11 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.foamix.co.il
Company Research
Source: GlobeNewswire
REHOVOT, Israel and BRIDGEWATER, N.J., Oct. 10, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a clinical stage specialty pharmaceutical company, today announced it will present results from nine clinical trials in five posters relating to its investigational topical product candidates FMX101 for the treatment of moderate-to-severe acne and FMX103 for the treatment of moderate-to-severe papulopustular rosacea in adults, at the 39th Annual Fall Clinical Dermatology Conference® October 17-20 in Las Vegas, Nevada. Poster highlights include: Long-term safety and efficacy data from the open-label extension of two Phase III studies (Study 04 and Study 05) of FMX101 in patients with moderate-to-severe acne for a total treatment period of up to 52 weeks. Data from three 12-week Phase III studies (FX2014-04, FX2014-05, and FX2017-22) that showed the safety and tolerability of FMX101 in pediatric patients (ages 9 - 17) with moderate-to-sever
Show less
Read more
Impact Snapshot
Event Time:
FOMX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FOMX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FOMX alerts
High impacting FOAMIX PHARMACEUTICALS LTD news events
Weekly update
A roundup of the hottest topics